Search research articles
Contact Us
Filters
Showing results (111-120 of 252) with videos related to
Page
of 26
Sort By:
International Journal of Clinical Oncology
|
June 28, 2018
Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy
Masahiro Kawahira, Tomoya Yokota, Satoshi Hamauchi, et al.
ISRN Oncology
|
April 21, 2012
Nutrition support for head and neck squamous cell carcinoma patients treated with chemoradiotherapy: how often and how long?
Hiroto Ishiki, Yusuke Onozawa, Takashi Kojima, et al.
Life Sciences
|
November 14, 2006
Presence of beta-linked GalNAc residues on N-glycans of human thyroglobulin
Akira Takeya, Osamu Hosomi, Hironori Nishijima, et al.
The Oncologist
|
October 5, 2014
A phase I/II study of XELIRI plus bevacizumab as second-line chemotherapy for Japanese patients with metastatic colorectal cancer (BIX study)
Yasuo Hamamoto, Tatsuro Yamaguchi, Tomohiro Nishina, et al.
International Journal of Clinical Oncology
|
August 7, 2012
Endoscopic evaluation of primary tumor response in patients with metastatic colorectal cancer treated by systemic chemotherapy
Madoka Takao, Kentaro Yamazaki, Narikazu Boku, et al.
Japanese Journal of Clinical Oncology
|
June 14, 2012
Modified FOLFOX-6 therapy for heavily pretreated advanced gastric cancer refractory to fluorouracil, irinotecan, cisplatin and taxanes: a retrospective study
Kunihiro Tsuji, Hirofumi Yasui, Yusuke Onozawa, et al.
Cancer Science
|
August 8, 2015
Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)
Makoto Tahara, Nozomu Fuse, Junki Mizusawa, et al.
Japanese Journal of Clinical Oncology
|
June 21, 2019
Comparison of enteral nutrition with total parenteral nutrition for patients with locally advanced unresectable esophageal cancer harboring dysphagia in definitive chemoradiotherapy
Mitsuhiro Furuta, Tomoya Yokota, Takahiro Tsushima, et al.
American Journal of Veterinary Research
|
March 3, 2026
Predictive equations measuring lung and lung lobe volumes in dogs based on thoracic height and width show promise with adjustments for some breeds
Kentaro Yamazaki, Airi Kaneyama, Kosei Teraoka, et al.
Investigational New Drugs
|
September 13, 2014
Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations
Takayuki Yoshino, Yoshito Komatsu, Yasuhide Yamada, et al.
Page
of 26
Search research articles
Search
Showing results (111-120 of 252) with videos related to
Sort By:
Page
of 26
International Journal of Clinical Oncology
|
June 28, 2018
Primary prophylactic granulocyte colony-stimulating factor according to ASCO guidelines has no preventive effect on febrile neutropenia in patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy
Masahiro Kawahira, Tomoya Yokota, Satoshi Hamauchi, et al.
ISRN Oncology
|
April 21, 2012
Nutrition support for head and neck squamous cell carcinoma patients treated with chemoradiotherapy: how often and how long?
Hiroto Ishiki, Yusuke Onozawa, Takashi Kojima, et al.
Life Sciences
|
November 14, 2006
Presence of beta-linked GalNAc residues on N-glycans of human thyroglobulin
Akira Takeya, Osamu Hosomi, Hironori Nishijima, et al.
The Oncologist
|
October 5, 2014
A phase I/II study of XELIRI plus bevacizumab as second-line chemotherapy for Japanese patients with metastatic colorectal cancer (BIX study)
Yasuo Hamamoto, Tatsuro Yamaguchi, Tomohiro Nishina, et al.
International Journal of Clinical Oncology
|
August 7, 2012
Endoscopic evaluation of primary tumor response in patients with metastatic colorectal cancer treated by systemic chemotherapy
Madoka Takao, Kentaro Yamazaki, Narikazu Boku, et al.
Japanese Journal of Clinical Oncology
|
June 14, 2012
Modified FOLFOX-6 therapy for heavily pretreated advanced gastric cancer refractory to fluorouracil, irinotecan, cisplatin and taxanes: a retrospective study
Kunihiro Tsuji, Hirofumi Yasui, Yusuke Onozawa, et al.
Cancer Science
|
August 8, 2015
Phase I/II trial of chemoradiotherapy with concurrent S-1 and cisplatin for clinical stage II/III esophageal carcinoma (JCOG 0604)
Makoto Tahara, Nozomu Fuse, Junki Mizusawa, et al.
Japanese Journal of Clinical Oncology
|
June 21, 2019
Comparison of enteral nutrition with total parenteral nutrition for patients with locally advanced unresectable esophageal cancer harboring dysphagia in definitive chemoradiotherapy
Mitsuhiro Furuta, Tomoya Yokota, Takahiro Tsushima, et al.
American Journal of Veterinary Research
|
March 3, 2026
Predictive equations measuring lung and lung lobe volumes in dogs based on thoracic height and width show promise with adjustments for some breeds
Kentaro Yamazaki, Airi Kaneyama, Kosei Teraoka, et al.
Investigational New Drugs
|
September 13, 2014
Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations
Takayuki Yoshino, Yoshito Komatsu, Yasuhide Yamada, et al.
Page
of 26